🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Short Bowel Syndrome (SBS) in Adults

Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome NCT07691125Phase 42 sites📍 Xiamen📍 Nanjing Changchun GeneScience Pharmaceutical Co., Ltd. · Tests: rhGH injection Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects NCT04775706Phase 215 sites📍 Boston📍 Cleveland📍 Leuven Hanmi Pharmaceutical Company Limited · Tests: HM15912 Active, Placebo Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) NCT06904872Phase 28 sites📍 Aachen📍 Berlin📍 Essen Napo Therapeutics, S.p.A. · Tests: Crofelemer Powder for Oral Solution, Matched Placebo Powder for Oral Solution A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF) NCT07742735Phase 394 sites📍 Los Angeles📍 Denver📍 Washington D.C. VectivBio AG · Tests: Apraglutide, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy